Article Reference Can concomitant-boost accelerated radiotherapy be adopted as routine treatment for head-and-neck cancers? A 10-year single-institution experience ALLAL, Abdelkarim Said, et al. Abstract Accelerated schedules are effective in overcoming repopulation during radiotherapy (RT) for head-and-neck cancers, but their feasibility is compromised by increased toxicity. The therapeutic ratio may be particularly favorable for 5-week regimens. This study reports the 10-year experience of a single institution in the routine use of concomitant boost RT as standard radical treatment in all but the most favorable stage patients. ALLAL, Abdelkarim Said, et al. Can concomitant-boost accelerated radiotherapy be adopted as routine treatment for head-and-neck cancers? A 10-year single-institution experience. International Journal of Radiation Oncology, Biology, Physics, 2004, vol. 58, no. 5, p. 1431-6 DOI : 10.1016/j.ijrobp.2003.09.017 PMID : 15050320 Available at: http://archive-ouverte.unige.ch/unige:33112 Disclaimer: layout of this document may differ from the published version. 1 / 1